Recent developments in cancer care continue to provide optimism for patients. Scientists are diligently exploring novel approaches, including harnessing the immune system, targeted agents, and precision healthcare . A significant finding published this week showcases the effectiveness of a new drug in managing advanced NSCLC. Furthermore, continued